Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regional variation in colorectal cancer testing and geographic availability of care in a publicly insured population.
Wheeler SB, Kuo TM, Goyal RK, Meyer AM, Hassmiller Lich K, Gillen EM, Tyree S, Lewis CL, Crutchfield TM, Martens CE, Tangka F, Richardson LC, Pignone MP. Wheeler SB, et al. Among authors: martens ce. Health Place. 2014 Sep;29:114-23. doi: 10.1016/j.healthplace.2014.07.001. Epub 2014 Jul 24. Health Place. 2014. PMID: 25063908 Free PMC article.
Multilevel predictors of colorectal cancer testing modality among publicly and privately insured people turning 50.
Wheeler SB, Kuo TM, Meyer AM, Martens CE, Hassmiller Lich KM, Tangka FK, Richardson LC, Hall IJ, Smith JL, Mayorga ME, Brown P, Crutchfield TM, Pignone MP. Wheeler SB, et al. Among authors: martens ce. Prev Med Rep. 2016 Dec 7;6:9-16. doi: 10.1016/j.pmedr.2016.11.019. eCollection 2017 Jun. Prev Med Rep. 2016. PMID: 28210537 Free PMC article.
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
Reeve BB, McFatrich M, Pinheiro LC, Weaver MS, Sung L, Withycombe JS, Baker JN, Mack JW, Waldron MK, Gibson D, Tomlinson D, Freyer DR, Mowbray C, Jacobs S, Palma D, Martens CE, Gold SH, Jackson KD, Hinds PS. Reeve BB, et al. Among authors: martens ce. Pediatr Blood Cancer. 2017 Mar;64(3):10.1002/pbc.26261. doi: 10.1002/pbc.26261. Epub 2016 Sep 21. Pediatr Blood Cancer. 2017. PMID: 27650708 Free PMC article.
Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©).
Kaiser K, Yount SE, Martens CE, Webster KA, Shaunfield S, Sparling A, Peipert JD, Cella D, Rottinghaus ST, Donato BMK, Wells R, Tomazos I. Kaiser K, et al. Among authors: martens ce. Patient Prefer Adherence. 2020 Apr 5;14:705-715. doi: 10.2147/PPA.S233830. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 32308375 Free PMC article.
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria.
Peipert JD, Kulasekararaj AG, Gaya A, Langemeijer SMC, Yount S, Gonzalez-Fernandez FA, Ojeda Gutierrez E, Martens C, Sparling A, Webster KA, Cella D, Tomazos I, Ogawa M, Piatek CI, Wells R, Sicre de Fontbrune F, Röth A, Mitchell L, Hill A, Kaiser K. Peipert JD, et al. PLoS One. 2020 Sep 4;15(9):e0237497. doi: 10.1371/journal.pone.0237497. eCollection 2020. PLoS One. 2020. PMID: 32886668 Free PMC article. Clinical Trial.